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Background:  The purpose of this study was to determine the optimal dose of remifentanil for minimizing 
hemodynamic changes during intubation and reducing propofol-induced pain in elderly patients. 
Methods:  In a randomized prospective study, 60 patients (ASA I-II, elder than 65 years) were enrolled to determine 
which of two target remifentanil blood concentrations (3 ng/ml, 5 ng/ml) was required to blunt hemodynamic 
changes during intubation and to reduce propofol-induced pain.  After the target effect site concentration of 
remifentanil had been reached, the target controlled infusion of propofol was started and propofol-induced pain 
was recorded.  Blood pressure and heart rate were recorded at baseline, just before intubation and 1, 3, 5 min after 
intubation.
Results:  There were no significant differences in the hemodynamic parameters between two groups, but not in 
arterial pressure at just before intubation and 1 minute after intubation.  However, the group R5 (5 ng/ml) showed 
significantly less intense pain induced by propofol than in the group R3 (3 ng/ml).
Conclusions:  The results suggest that the group R5 provide more relief in propofol induced pain than the group R3, 
but showed great possibility of hypotension and bradycardia in both groups, which means it should be used with 
cautions in the elderly patients.  (Korean J Anesthesiol 2010; 58: 532-536)
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Introduction
    As aging progresses, there is more stiffness of the heart and 
blood vessels, a decrease in stimulus to the beta-adrenergic 
receptor, unbalance and disorder of the autonomic nerve 
system, and changes in the conduction system. Therefore, the 
morbidity rate caused by cardiovascular diseases increases, and 
the hemodynamic changes to the stimuli can happen frequently 
and severely. An older person has a sensitive response to 
intravenous anesthetics such as propofol and lowered clearance, 
so he or she becomes 30-50% more sensitive to propofol. The 
same happens with opioid analgesics, and the duration of 
drug action lengthens because of the decrease in clearance. 
Therefore, it is more predictable and appropriate to inject drugs 
of short context-sensitive half-life, such as remifentanil. For 
temporary intravenous injections as well as constant injection, 
the changes in pharmacokinetics of remifentanil are much fewer 
than other opioid analgesics; remifentanil is recommended 
as the opioid analgesics to anesthetize an older person [1]. In 
addition, as endo-tracheal intubation itself may induce harmful 
hemodynamic changes such as the increase in blood pressure 
and heart rate, arrhythmia and myocardial ischemia [2]. For 
elderly patients, it is important to set an adequate remifentanil 
control level to minimize the hemodynamic change caused 
by the intubation and to decrease the pain due to intravenous 
injection, which is the side effect of propofol. 
    This study intends to clarify the adequate effect-site concent-
ration of remifentanil at the propofol effect-site concentration 
of 4 μg/ml when the propofol-remifentanil total intravenous 
anesthesia was induced for elderly patients. 
Materials and Methods
    Sixty ASA I or II patients over the age 65 and regardless of 
sex, who are undergoing regular surgery, were randomly 
selected. This study has gotten the permission of the Clinical 
Ethics Committee of our hospital and the agreement of the 
patients after a full explanation of the purpose and method of 
the study beforehand. Among the target patients, patients over 
the Mallampati classification III were excluded from the study, 
and the cases that have two or more trials of endo-tracheal 
intubation were also excluded.
    The sixty patients were randomized into two groups, and they 
were given remifentanil 3 ng/ml (R3 group, n = 30) or 5 ng/ml 
(R5 group, n = 30). No patients had received premedication 
before their arrival in the operating room. Electrocardiography, 
non-invasive blood pressure monitor and pulse oximeter were 
attached to the patients when they arrived at the operating 
room. For the anesthesia, target controlled infusion via syringe 
pump (Orchestra
Ⓡ, Fresenius Vial, France) was used to induce 
the propofol-remifentanil total intravenous anesthesia. When 
remifentanil reached the pre-set concentration, propofol was 
injected into the effect-site concentration of 4 μg/ml. After 
unconsciousness was confirmed, the intravenous injection of 
vecuronium 0.15 mg/kg was administered; after 3 minutes, the 
intubation was performed. 
    Before the intubation, the Mallampati classification was 
recorded for the airway evaluation, the Cormack and Lehane 
grade and the POGO (percentage of glottic opening) score were 
recorded for the airway evaluation. 
    In order to compare the side effects right after the injection 
of remifentanil, we checked for coughing, vertigo, and chest 
pain. After remifentanil reached the pre-set concentration, 
the intravenous injection of propofol began and the degree of 
pain felt by the patients in the injected part was observed with 
the four-point verbal categorical scoring system used by King 
et al. [3] through facial expression, tears, withdrawal behavior, 
screaming, and complaining of pain. Responses were classified 
into four categories: there were no unpleasant feelings (none), 
no facial expression of pain but reported feelings of pain when 
asked (mild), no frown or withdrawal response but complaints 
of pain (moderate) and the existence of tears, and frown and 
withdrawal response (severe). 
    Blood pressure and heart rate were measured upon arrival 
at the operation room, just before the intubation, and after 1 
minute, 3 minutes, and 5 minutes of intubation; the measure-
ment upon arrival at the operation room was set as the baseline. 
The parameters between the two groups were compared and 
within the same group, the changes in blood pressure and heart 
rate just before intubation, after 1 minute, 3 minutes and 5 
minutes of intubation were compared with the baseline.
    There was a study about the frequency of pain after the intra-
venous injection of propofol and after the premedication of 
remifentanil; the frequency was 51%. In this study for elderly 
patients, the frequency of pain after the intravenous injection of 
propofol was expected to be 20% and the number of meaningful 
samples were calculated with 80% power and the two-sided 
type I error = 0.05, and the result is 30. The number of target 
samples was set at 30 patients per group. All the measurements 
were marked as mean ± standard deviation, and SPSS (version 
12.0, SPSS Inc, Chicago, USA) was used for statistical analysis. 
Chi-square test was used for inter-group comparison of gender. 
Unpaired T test was used to compare age, height, weight and 
the measurement between the two groups in time. Paired T test 
was used to compare the measurement within the same group. 
A P value under 0.05 was determined as statistically significant. 
Results
    There was no significant difference in the age, sex, height 534 www.ekja.org
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and weight between the two groups (Table 1), and there was 
also no significant difference in the Mallampati classification, 
the Cormack and Lehane grade, the POGO score, and the 
intubation time (Table 2). 
    Among the side effects of the injection of remifentanil 
between the two groups, the frequency of coughing significant 
increased in the R5 group and the others had no significant 
difference (Table 3). Concerning the injection of propofol, in 
the R3 group, 3 patients complained of severe pain, 7 moderate, 
and 13 mild, while in the R5 group there was just 1 moderate 
complaint and 6 mild; the difference was significant (Table 4). 
    When we compare the two groups, the systolic arterial pressure 
just before intubation meaningfully decreased in the R5 group, 
and after 1 minute of intubation, the systolic and diastolic 
arterial pressure excluding the heart rate were meaningfully 
lowered in the R5 group than the R3 group. The hemodynamic 
parameters on 3 minutes and 5 minutes after intubation of 
the two groups had no significant difference. Within the R3 
group, all the hemodynamic parameters just before intubation, 
3 minutes and 5 minutes after intubation- excluding 1 
minute after the intubation-had significantly differed from 
the status before the anesthesia; within the R5 group, all the 
hemodynamic parameters, excluding the heart rate after 1 
minute of the intubation, had significant difference from the 
status before the anesthesia (Table 5).
Table 1. Demographic Data
Group R3 (n = 30) R5 (n = 30)
Age (year)
Weight (kg)
Height (cm)
Gender (M/F)
ASA I/II
Hypertension
Heart disease
Cerebrovascular disease
70.4 ± 4.9 
(From 65 to 83)
59.9 ± 8.4
157.8 ± 8.3
16/14
13/17
12
  0
  1
68.4 ± 2.8 
(From 65 to 74)
58.8 ± 7.8
157.2 ± 9.2
16/14
17/13
12
  1
  0
Values are number of patients or mean ± SD. R3: effect site concen-
tration of remifentanil 3 ng/ml, R5: effect site concentration of remi-
fentanil 5 ng/ml.
Table 2. Laryngeal View and Intubation Time
Group   R3 (n = 30) R5 (n = 30)
Mallampati classification
Cormack and Lehane grade
POGO score
Intubation time (sec)
I 
II 
1
2
 
 
18 
12
22
  8
55.7 ± 41.2 
14.6 ± 7.4 
20
10
28
  2
62.0 ± 29.0
11.9 ± 3.6
Values are number of patients or mean ± SD. Mallampati classifica-
tion: I: full visibility of tonsils, uvula and soft palate, II: visibility of 
hard and soft palate, upper portion of tonsils and uvula. Cormack 
and Lehane grade 1: visualization of entire laryngeal aperture, 2: vi-
sualization of just the posterior portion of laryngeal aperture. POGO 
score: Represents the linear span extending from the anterior com-
missure to the interarytenoid notch of the vocal cords.  R3: effect site 
concentration of remifentanil 3 ng/ml, R5: effect site concentration 
of remifentanil 5 ng/ml.
Table 5. Hemodynamic Changes 
Baseline Preintubation A1 A3 A5
HR (beats/min)
SAP (mmHg)
DAP (mmHg)
MAP (mmHg)
R3
R5
R3
R5
R3
R5
R3
R5
  74 ± 12.6
  75 ± 13.2
141 ± 15.7
148 ± 18.9
84 ± 9.4
88 ± 9.6
104 ± 21.8
  115 ± 13.4*
62 ± 9.8
†
59 ± 6.7
†
  97 ± 17.7
†
     87 ± 18.3*,†
57 ± 8.3
†
  54 ± 10.2
†
  75 ± 20.4
†
  67 ± 13.8
†
  76 ± 13.4
  73 ± 12.6
131 ± 25.2
      107 ± 18.3*,†
  81 ± 14.7
        70 ± 14.9*,†
101 ± 19.0
        86 ± 17.8*,†
  65 ± 11.0
†
  65 ± 10.2
†
107 ± 19.1
†
  98 ± 16.2
†
  64 ± 11.2
†
62 ± 9.8
†
  81 ± 12.4
†
  76 ± 12.4
†
  61 ± 11.1
†
  62 ± 10.3
†
  95 ± 14.0
†
  94 ± 15.2
†
59 ± 8.9
†
  59 ± 11.4
†
  73 ± 10.1
†
  73 ± 12.8
†
Values are mean ± SD. HR: heart rate, SAP: systolic arterial pressure, DAP: diastolic arterial pressure, MAP: mean arterial pressure, Preintuba-
tion: just before insertion of laryngoscope, A1, A3 and A5: 1, 3 and 5 minutes after intubation. R3: effect site concentration of remifentanil 3 ng/
ml, R5: effect site concentration of remifentanil 5 ng/ml. *P < 0.05 compared with R3, 
†P < 0.05 compared with baseline. 
Table 3. Incidence of Complications on Remifentanil
Group R3 (n = 30) R5 (n = 30)
Cough
Chest tightness
Dizziness
  0
  0
19
    4*
  0
19
Values are number of patients. R3: effect site concentration of remi-
fentanil 3 ng/ml, R5: effect site concentration of remifentanil 5 ng/
ml. *P < 0.05 compared with R3. 
Table 4. Pain on Injection of Propofol
R3 (n = 30) R5 (n = 30)*
None
Mild
Moderate
Severe
  7
13
  7
  3
23
  6
  1
  0
Values are number of patients. R3: effect site concentration of remi-
fentanil 3 ng/ml, R5: effect site concentration of remifentanil 5 ng/
ml. *P < 0.05 compared with R3. 535 www.ekja.org
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Discussion
    It is important to choose the appropriate anesthetic agent 
and to inject the right dose for elderly patients since it is 
probable they have severe hemodynamic changes in anesthesia 
because of their physiological changes accompanying aging 
and aging-involved diseases; even a little dose may provoke 
sensitive medical action. It is essential to find out the adequate 
inspired concentration in order to minimize the depression 
of the cardiovascular system and to maintain intra-operative 
narcohypnosis when propofol is intravenously injected for the 
induction and maintenance of anesthesia for an older person. 
A study reported that 4 μg/ml of propofol concentration might 
induce adequate unconsciousness for 90% of the patients when 
adults were induced by anesthesia [4,5], and recent studies 
report that the propofol concentration to maintain the BIS value 
as 40-50 should be 3.4 μg/ml, 3.5 μg/ml and 3.75 μg/ml [6-8]. 
In this study, the effect-site concentration of propofol was set as 
4 μg/ml based on the above results. 
    According to previous reports, the pain around the injected 
part frequently happened, 30-70%, when propofol was injected 
[9]; although the exact cause of the pain has not been clarified, 
a study reported that it might be because propofol itself irritates 
the arterial wall and activates kinin cascade [10]. Another 
study reported the correlation between the concentration of 
the emulsion and the degree of pain [11]. In order to decrease 
the pain, various studies are now being performed; recently, 
methods like the injection through a blood vessel with a 
large diameter, the premedication of drugs such as opioid 
analgesic, NSAID (non-steroidal anti-inflammatory drugs) 
or local anesthetic agent, and the injection of diluted or low-
temperature propofol itself are being used [10-15].
    This study intended to find out the adequate inspired con-
cent  ration of remifentanil without any other premedication 
to control the pain caused by the intravenous injection of 
propofol as well as to restrain the hemodynamic changes 
caused by intubation, only by controlling the concentration of 
remifentanil. 
    In a similar study regarding total intravenous anesthesia using 
propofol and remifentanil in cases of eldery patients, Xu et al. 
[16] reported that both remifentanil effect-site concentration 
4 ng/ml and 7 ng/ml blocked the response from the endo-
tracheal intubation, but 7 ng/ml had a high probability of 
hypotension; therefore 4 ng/ml was recommended. Park et al. 
[17] effectively restrained the hemodynamic changes at the 
remifentanil effect-site concentration of 2 ng/ml. However, at 4 
ng/ml there was severe bradycardia and hypotension, so 2 ng/
ml dose should be adequate. In addition, Tak et al. [18] found 
that the doses of remifentanil effect-site concentration 1 ng/ml 
and 3 ng/ml had a similar risk of hypotension, and the dose of 3 
ng/ml effectively restrained the changes of heart rate and blood 
pressure after intubation, decreasing the pain. In the studies 
where the target was not the elderly patients but other younger 
adult patients, Albertin et al. [6] reported that the adequate 
concentration needed to relax the sympathetic nerve system 
for intubation in order to induce anesthesia was remifentanil 5 
ng/ml. According to Kim et al. [19], the adequate remifentanil 
effect-site concentration for the intubation was 3 or 4 ng/ml.
    In regards to the total intravenous anesthesia, the adequate 
remifentanil effect-site concentration to block hemodynamic 
changes caused by intubation was largely affected by the 
concentration of propofol that was simultaneously injected. 
Because of their mutual synergism, the effect-site concentration 
of remifentanil may be lower or higher depending on the 
level of propofol concentration, Most studies sought to find 
the adequate remifentanil effect-site concentration based on 
propofol 3-4 μg/ml; however, Park et al. [17] recommended 
remifentanil 2 ng/ml; it is inferred that this is because their 
propofol effect-site target concentration was 5.4 μg/ml. 
    In the previous studies, the prevalent opinions are that the 
remifentanil concentration 2-4 ng/ml for elderly patients and 
3-5 ng/ml for adult patients should be adequate. Thereby in 
this study, the effect-site concentration of propofol was set to 4 
μg/ml, the concentration of remifentanil was set to 3 and 5 ng/
ml, and 60 members were randomized into two groups. The 
original plan was to study 3 groups of 30 members each with 3, 
5 and 7 ng/ml as well as high concentration, However, among 
7 patients of 7 ng/ml, 5 patients showed bradycardia with no 
response to atropine, and there was constant hypotension in 
spite of two or more injections of ephedrine. There is a report 
that the comparison of the injection of remifentanil 5, 10 and 
15 ng/ml showed a decrease of the cough response in 75%. At 
least at 10 ng/ml, the response caused by the endo-tracheal 
intubation was properly lowered the most [20]; however, many 
elderly patients have high blood pressure as an underlying 
disease even if they are ASA I, II, and they show different 
responses to the stimuli of blood vessels and the receptors 
because of their age; the highly-concentrated remifentanil was 
judged to be inadequate. 
    In this study, the survey of the two groups, the group of 3 ng/
ml and 5 ng/ml, illustrates that the duration and the frequency 
of intubation had no difference, and the cough response caused 
by endo-tracheal suctioning never happened since the survey 
was performed after the injection of the muscle relaxant. In 
the inter-group comparison, the systolic arterial pressure 
just before the intubation and 1 minute after intubation had 
meaningful difference, and there was a decrease in the R5 
group. In both groups, blood pressure and heart rate decreased 
just before intubation and 3 and 5 minutes after intubation 
than the baseline; the blood pressure after 1 minute was also 536 www.ekja.org
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meaningfully lower than the baseline in the R5 group, but had 
no difference in the R3 group; in both groups the hemodynamic 
changes due to intubation can effectively be restrained. Rather, 
in the R5 group, blood pressure and heart rate decreased with 
a great difference from the baseline, and therefore it might be 
relatively high concentration for elderly patients. However, in 
cases where propofol was injected after remifentanil reached 
3 or 5 ng/ml, more than half of the R3 group complained of 
pain, but the R5 group complained of mild pain or had no pain. 
For the premedication to suppress the pain of the intravenous 
injection of propofol, remifentanil 3 ng/ml seems to be 
insufficient and 5 ng/ml adequate. 
    As for the above results, it may be good news for elderly 
patients if the first remifentanil concentration is set to 5 ng/ml 
to decrease the pain of the intravenous injection of propofol 
and after unconsciousness, it should be lowered to 3 ng/ml 
to protect hypotension and bradycardia. However, elderly 
patients have great differences in sensitivity to anesthetic 
agents according to the morbidity rate or to the body index; 
therefore careful observation is needed when using more 
than remifentanil 3 ng/ml for elderly patients since they have 
high frequency and degree of hypotension. Further study 
of remifentanil concentration of 1, 2 and 3 ng/ml for elderly 
patients can produce more valuable results. 
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